Epstein Secrets

ned that the reoccurring TREM2-TYROBP pathway could be playing a main role in the onset of late Alzheimers. The discovery is critical, explains Dr. Bin Zhang, a co-lead author of the study and Associate Professor of Genetics and Genomic Sciences at Mount Sinai. Because we can now "evaluate drugs that impa

onset of late Alzheimers. The discovery is critical, explains Dr. Bin Zhang, a co-lead author of the study and Associate Professor of Genetics and Genomic Sciences at Mount Sinai. Because we can now "evaluate drugs that impact the TREM2-TYROBP pathway as potential therapies... and design more specific compounds

imer's but linked to brain inflammation, was shown to interact with TREM2, a gene recently connected to Alzheimer's. The discovery is critical, Dr. Bin Zhang explained, a co-author of the study and Associate Professor of Genetics and Genomic Sciences at Mount Sinai. "We can now evaluate drugs that impact

ntly connected to Alzheimer's. The discovery is critical, Dr. Bin Zhang explained, a co-author of the study and Associate Professor of Genetics and Genomic Sciences at Mount Sinai. "We can now evaluate drugs that impact the TFtEM2- TYROBP pathway as potential therapies... and design more specific compounds that t

imer's but linked to brain inflammation, was shown to interact with TREM2, a gene recently connected to Alzheimer's. The discovery is critical, Dr. Bin Zhang explained, a co-author of the study and Associate Professor of Genetics and Genomic Sciences at Mount Sinai. "We can now evaluate drugs that impact

ntly connected to Alzheimer's. The discovery is critical, Dr. Bin Zhang explained, a co-author of the study and Associate Professor of Genetics and Genomic Sciences at Mount Sinai. "We can now evaluate drugs that impact the TREM2- TYROBP pathway as potential therapies... and design more specific compounds that ta

ned that the reoccurring TREM2-TYROBP pathway could be playing a main role in the onset of late Alzheimers. The discovery is critical, explains Dr. Bin Zhang, a co-lead author of the study and Associate Professor of Genetics and Genomic Sciences at Mount Sinai. Because we can now "evaluate drugs that impa

onset of late Alzheimers. The discovery is critical, explains Dr. Bin Zhang, a co-lead author of the study and Associate Professor of Genetics and Genomic Sciences at Mount Sinai. Because we can now "evaluate drugs that impact the TREM2-TYROBP pathway as potential therapies... and design more specific compounds